US9453251B2
(en)
|
2002-10-08 |
2016-09-27 |
Pfenex Inc. |
Expression of mammalian proteins in Pseudomonas fluorescens
|
DE10303974A1
(de)
|
2003-01-31 |
2004-08-05 |
Abbott Gmbh & Co. Kg |
Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
|
BRPI0513826A2
(pt)
|
2004-07-26 |
2010-06-22 |
Dow Global Technologies Inc |
processo para expressão de proteìna melhorada através de engenharia de cepa
|
BRPI0609797B8
(pt)
*
|
2005-05-20 |
2021-05-25 |
Ablynx Nv |
nanocorpos melhorados para o tratamento de desordens mediadas por agregação
|
EP1785434A1
(en)
*
|
2005-11-11 |
2007-05-16 |
Ludwig-Maximilians-Universität München |
Targeting and tracing of antigens in living cells
|
RU2442793C2
(ru)
|
2005-11-30 |
2012-02-20 |
Эбботт Лэборетриз |
АНТИТЕЛА ПРОТИВ ГЛОБУЛОМЕРА Аβ, ИХ АНТИГЕНСВЯЗЫВАЮЩИЕ ЧАСТИ, СООТВЕТСТВУЮЩИЕ ГИБРИДОМЫ, НУКЛЕИНОВЫЕ КИСЛОТЫ, ВЕКТОРЫ, КЛЕТКИ-ХОЗЯЕВА, СПОСОБЫ ПОЛУЧЕНИЯ УКАЗАННЫХ АНТИТЕЛ, КОМПОЗИЦИИ, СОДЕРЖАЩИЕ УКАЗАННЫЕ АНТИТЕЛА, ПРИМЕНЕНИЯ УКАЗАННЫХ АНТИТЕЛ И СПОСОБЫ ИСПОЛЬЗОВАНИЯ УКАЗАННЫХ АНТИТЕЛ
|
KR101667623B1
(ko)
|
2005-11-30 |
2016-10-19 |
애브비 인코포레이티드 |
아밀로이드 베타 단백질에 대한 모노클로날 항체 및 이의 용도
|
KR20150098683A
(ko)
|
2005-12-12 |
2015-08-28 |
에이씨 이뮨 에스.에이. |
치료적 특성을 갖는 베타 1-42 특이적인 단일클론성 항체
|
US20100226920A1
(en)
*
|
2006-03-27 |
2010-09-09 |
Ablynx N.V. |
Medical delivery device for therapeutic proteins based on single domain antibodies
|
SG173385A1
(en)
|
2006-07-14 |
2011-08-29 |
Ac Immune S A Ch |
Humanized antibody against amyloid beta
|
AU2007293614A1
(en)
*
|
2006-09-08 |
2008-03-13 |
Ablynx N.V. |
Serum albumin binding proteins with long half-lives
|
WO2008043821A1
(en)
*
|
2006-10-11 |
2008-04-17 |
Ablynx N. V. |
Amino acid sequences that bind to serum proteins in a manner that is essentially independent of the ph, compounds comprising the same, and use thereof
|
US20100034194A1
(en)
*
|
2006-10-11 |
2010-02-11 |
Siemens Communications Inc. |
Eliminating unreachable subscribers in voice-over-ip networks
|
AU2007310838A1
(en)
*
|
2006-10-27 |
2008-05-02 |
Ablynx N.V. |
Intranasal delivery of polypeptides and proteins
|
US8455626B2
(en)
*
|
2006-11-30 |
2013-06-04 |
Abbott Laboratories |
Aβ conformer selective anti-aβ globulomer monoclonal antibodies
|
EP2102241A2
(en)
|
2006-12-15 |
2009-09-23 |
Ablynx N.V. |
Amino acid sequences that modulate the interaction between cells of the immune system
|
WO2008074840A2
(en)
|
2006-12-19 |
2008-06-26 |
Ablynx N.V. |
Amino acid sequences directed against a metalloproteinase from the adam family and polypeptides comprising the same for the treatment of adam-related diseases and disorders
|
EP2115004A2
(en)
|
2006-12-19 |
2009-11-11 |
Ablynx N.V. |
Amino acid sequences directed against gpcrs and polypeptides comprising the same for the treatment of gpcr-related diseases and disorders
|
EP2101801A1
(en)
*
|
2006-12-20 |
2009-09-23 |
Ablynx N.V. |
Oral delivery of polypeptides
|
PL2104682T3
(pl)
|
2007-01-11 |
2017-03-31 |
Michael Bacher |
Diagnostyka i leczenie choroby Alzheimera i innych chorób neurodegeneracyjnych
|
ES2615454T3
(es)
*
|
2007-01-18 |
2017-06-07 |
Eli Lilly And Company |
Fab pegilado contra el amiloide beta
|
JP2010518839A
(ja)
*
|
2007-02-21 |
2010-06-03 |
アブリンクス エン.ヴェー. |
血管内皮増殖因子に指向性を有するアミノ酸配列、及び過度の及び/もしくは病的な血管形成又は血管新生を特徴とする症状及び疾患を治療するためにこれを含むポリペプチド
|
WO2008104386A2
(en)
|
2007-02-27 |
2008-09-04 |
Abbott Gmbh & Co. Kg |
Method for the treatment of amyloidoses
|
US8280711B2
(en)
|
2007-03-12 |
2012-10-02 |
ESBATech, an Alcon Biomedical Research Unit, LLC. |
Sequence based engineering and optimization of single chain antibodies
|
EP1978035A1
(en)
*
|
2007-04-05 |
2008-10-08 |
Hans-Knöll-Institut Leibniz-Institut für Naturstoff-Forschung |
Anti-amyloid antibodies and their use in diagnosis and therapy of amyloid diseases
|
US9580719B2
(en)
|
2007-04-27 |
2017-02-28 |
Pfenex, Inc. |
Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
|
EP2142651B1
(en)
|
2007-04-27 |
2013-05-22 |
Pfenex Inc. |
Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
|
RS53793B1
(en)
*
|
2007-06-12 |
2015-06-30 |
Ac Immune S.A. |
HUMANIZED ANTIBODIES AGAINST BETA AMYLOID
|
US8613923B2
(en)
|
2007-06-12 |
2013-12-24 |
Ac Immune S.A. |
Monoclonal antibody
|
US8048420B2
(en)
*
|
2007-06-12 |
2011-11-01 |
Ac Immune S.A. |
Monoclonal antibody
|
EP2008666A1
(en)
*
|
2007-06-29 |
2008-12-31 |
Institut Pasteur |
Use of VHH antibodies for the preparation of peptide vectors for delivering a substance of interest and their applications
|
EP2009445A1
(en)
*
|
2007-06-29 |
2008-12-31 |
Institut Pasteur |
Use of a camelid single-domain antibody for detecting an oligomeric form of an amyloid beta peptide and its applications
|
US10214588B2
(en)
|
2007-07-03 |
2019-02-26 |
Ablynx N.V. |
Providing improved immunoglobulin sequences by mutating CDR and/or FR positions
|
JP2010533004A
(ja)
|
2007-07-13 |
2010-10-21 |
バク アイピー ベスローテン フェンノートシャップ |
哺乳動物IgGと結合する単一ドメイン抗原結合タンパク質
|
US20100297012A1
(en)
*
|
2007-10-05 |
2010-11-25 |
Andrea Pfeifer |
Humanized antibody
|
RU2604181C2
(ru)
*
|
2007-10-05 |
2016-12-10 |
Дженентек, Инк. |
Применение антитела против амилоида бета при глазных заболеваниях
|
PE20091163A1
(es)
|
2007-11-01 |
2009-08-09 |
Wyeth Corp |
Anticuerpos para gdf8
|
AU2008328779B2
(en)
|
2007-11-27 |
2014-06-05 |
Ablynx N.V. |
Amino acid sequences directed against HER2 and polypeptides comprising the same for the treatment of cancers and/or tumors
|
EP2068124A1
(en)
|
2007-12-04 |
2009-06-10 |
Metris IPR N.V. |
Articulated arm measuring machine endowed with multiple measurement disks
|
CA2717015A1
(en)
|
2008-03-05 |
2009-09-11 |
Ablynx Nv |
Novel antigen binding dimer-complexes, methods of making and uses thereof
|
US9908943B2
(en)
|
2008-04-03 |
2018-03-06 |
Vib Vzw |
Single domain antibodies capable of modulating BACE activity
|
DK2281005T3
(en)
|
2008-04-03 |
2014-02-24 |
Vib Vzw |
Single domain antibodies able to modulate bace1 activity
|
EP2260058A2
(en)
|
2008-04-07 |
2010-12-15 |
Ablynx N.V. |
Single variable domains against the notch pathways
|
AU2009237662A1
(en)
|
2008-04-17 |
2009-10-22 |
Ablynx N.V. |
Peptides capable of binding to serum proteins and compounds, constructs and polypeptides comprising the same
|
KR20110020825A
(ko)
|
2008-05-16 |
2011-03-03 |
아블린쓰 엔.브이. |
Cxcr4 및 다른 gpcr에 대해 유도된 아미노산 서열 및 이를 포함하는 화합물
|
LT2285408T
(lt)
|
2008-06-05 |
2019-01-25 |
Ablynx N.V. |
Aminorūgščių sekos, nukreiptos prieš viruso apvalkalo baltymus, ir tokias sekas turintys polipeptidai, skirti virusinių ligų gydymui
|
US8444976B2
(en)
|
2008-07-02 |
2013-05-21 |
Argen-X B.V. |
Antigen binding polypeptides
|
EP2143735A1
(en)
*
|
2008-07-10 |
2010-01-13 |
Institut Pasteur |
Variable domains of camelid heavy-chain antibodies directed against glial fibrillary acidic proteins
|
CA2731617A1
(en)
|
2008-07-22 |
2010-01-28 |
Maria Joao Saraiva |
Amino acid sequences directed against multitarget scavenger receptors and polypeptides
|
US20100136584A1
(en)
*
|
2008-09-22 |
2010-06-03 |
Icb International, Inc. |
Methods for using antibodies and analogs thereof
|
WO2010033913A1
(en)
*
|
2008-09-22 |
2010-03-25 |
Icb International, Inc. |
Antibodies, analogs and uses thereof
|
CA2737752A1
(en)
*
|
2008-09-26 |
2010-04-01 |
Wyeth Llc |
Compatible display vector systems
|
JP2012503982A
(ja)
|
2008-09-26 |
2012-02-16 |
ワイス・エルエルシー |
適合性ディスプレイベクター系
|
US9393304B2
(en)
|
2008-10-29 |
2016-07-19 |
Ablynx N.V. |
Formulations of single domain antigen binding molecules
|
CN102272154A
(zh)
|
2008-10-29 |
2011-12-07 |
惠氏有限责任公司 |
单域抗原结合性分子的纯化方法
|
AU2009329501B2
(en)
|
2008-12-19 |
2015-11-26 |
Ablynx N.V. |
Genetic immunization for producing immunoglobulins against cell-associated antigens such as P2X7, CXCR7 or CXCR4
|
EP2403873A1
(en)
|
2009-03-05 |
2012-01-11 |
Ablynx N.V. |
Novel antigen binding dimer-complexes, methods of making/avoiding and uses thereof
|
US9265834B2
(en)
|
2009-03-05 |
2016-02-23 |
Ablynx N.V. |
Stable formulations of polypeptides and uses thereof
|
EP2417163B1
(en)
|
2009-04-10 |
2019-02-27 |
Ablynx N.V. |
Improved amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of il-6r related diseases and disorders
|
EP3828201A1
(en)
|
2009-04-30 |
2021-06-02 |
Ablynx N.V. |
Method for the production of domain antibodies
|
CA2761298A1
(en)
*
|
2009-05-15 |
2010-11-18 |
The University Of Kentucky Research Foundation |
Treatment of mci and alzheimer's disease
|
US9968574B2
(en)
*
|
2009-05-15 |
2018-05-15 |
The University Of Kentucky Research Foundation |
Treatment of MCI and Alzheimer's disease
|
CN102459332B
(zh)
|
2009-06-05 |
2015-08-19 |
埃博灵克斯股份有限公司 |
用于预防和/或治疗呼吸道感染的单价、二价和三价抗人呼吸道合胞病毒(hrsv)纳米抗体构建体
|
HUE051430T2
(hu)
|
2009-07-10 |
2021-03-01 |
Ablynx Nv |
Eljárás variábilis domének elõállítására
|
KR20130127547A
(ko)
*
|
2009-07-30 |
2013-11-22 |
화이자 백신스 엘엘씨 |
항원성 타우 펩타이드 및 이의 용도
|
EP2473527B1
(en)
|
2009-09-03 |
2016-11-30 |
Ablynx N.V. |
Stable formulations of polypeptides and uses thereof
|
UY32917A
(es)
|
2009-10-02 |
2011-04-29 |
Boehringer Ingelheim Int |
Moléculas de unión a dll-4
|
US20110172398A1
(en)
|
2009-10-02 |
2011-07-14 |
Boehringer Ingelheim International Gmbh |
Bispecific binding molecules for anti-angiogenesis therapy
|
EP2507262A1
(en)
|
2009-11-30 |
2012-10-10 |
Ablynx N.V. |
Improved amino acid sequences directed against human respiratory syncytial virus (hrsv) and polypeptides comprising the same for the prevention and/or treatment of respiratory tract infections
|
WO2011073180A1
(en)
|
2009-12-14 |
2011-06-23 |
Ablynx N.V. |
Single variable domain antibodies against ox40l, constructs and therapeutic use
|
WO2011083140A1
(en)
|
2010-01-08 |
2011-07-14 |
Ablynx Nv |
Immunoglobulin single variable domain directed against human cxcr4
|
JP2013518853A
(ja)
|
2010-02-05 |
2013-05-23 |
アブリンクス エン.ヴェー. |
血清アルブミンと結合することが可能なペプチド並びにこれを含む化合物、構築物及びポリペプチド
|
US9120855B2
(en)
|
2010-02-10 |
2015-09-01 |
Novartis Ag |
Biologic compounds directed against death receptor 5
|
WO2011098518A2
(en)
|
2010-02-11 |
2011-08-18 |
Ablynx Nv |
Delivery of immunoglobulin variable domains and constructs thereof
|
CN102753148B
(zh)
|
2010-02-11 |
2018-01-26 |
埃博灵克斯股份有限公司 |
用于制备气雾剂的方法和组合物
|
AP2012006359A0
(en)
|
2010-03-03 |
2012-08-31 |
Boehringer Ingelheim Int |
Biparatopic abeta binding polypeptides
|
MX360403B
(es)
|
2010-04-15 |
2018-10-31 |
Abbvie Inc |
Proteinas de union a amiloide beta.
|
AU2011254557B2
(en)
|
2010-05-20 |
2015-09-03 |
Ablynx Nv |
Biological materials related to HER3
|
WO2011161263A1
(en)
|
2010-06-25 |
2011-12-29 |
Ablynx Nv |
Pharmaceutical compositions for cutaneous administration
|
AU2011277983C1
(en)
*
|
2010-07-16 |
2016-09-29 |
Ablynx Nv |
Modified single domain antigen binding molecules and uses thereof
|
RU2607368C2
(ru)
|
2010-07-30 |
2017-01-10 |
Ац Иммуне С.А. |
Безопасные и функциональные гуманизированные антитела
|
EP3533803B1
(en)
|
2010-08-14 |
2021-10-27 |
AbbVie Inc. |
Anti-amyloid-beta antibodies
|
US20120225081A1
(en)
|
2010-09-03 |
2012-09-06 |
Boehringer Ingelheim International Gmbh |
Vegf-binding molecules
|
DK2632946T3
(en)
|
2010-10-29 |
2018-03-12 |
Ablynx Nv |
PROCEDURE FOR MANUFACTURING VARIABLE IMMUNGLOBULIN SINGLE DOMAINS
|
AU2011328246B2
(en)
|
2010-11-08 |
2016-06-30 |
Ablynx N.V. |
CXCR2 binding polypeptides
|
JP6173216B2
(ja)
|
2010-11-26 |
2017-08-02 |
モレキュラー・パートナーズ・アーゲーMolecular Partners Ag |
設計アンキリンリピートタンパク質のための改善されたキャッピングモジュール
|
WO2012109624A2
(en)
|
2011-02-11 |
2012-08-16 |
Zyngenia, Inc. |
Monovalent and multivalent multispecific complexes and uses thereof
|
PT2691415T
(pt)
|
2011-03-28 |
2018-10-19 |
Ablynx Nv |
Método para produção de formulações sólidas compreendendo domínios variáveis únicos de imunoglobulina
|
US9527925B2
(en)
|
2011-04-01 |
2016-12-27 |
Boehringer Ingelheim International Gmbh |
Bispecific binding molecules binding to VEGF and ANG2
|
US20130078247A1
(en)
|
2011-04-01 |
2013-03-28 |
Boehringer Ingelheim International Gmbh |
Bispecific binding molecules binding to dii4 and ang2
|
UA117218C2
(uk)
|
2011-05-05 |
2018-07-10 |
Мерк Патент Гмбх |
Поліпептид, спрямований проти il-17a, il-17f та/або il17-a/f
|
EP2707382B1
(en)
|
2011-05-09 |
2019-07-17 |
Ablynx NV |
Method for the production of immunoglobulin single variable domains
|
WO2012163887A1
(en)
|
2011-05-27 |
2012-12-06 |
Ablynx Nv |
Inhibition of bone resorption with rankl binding peptides
|
EP2723772A1
(en)
|
2011-06-23 |
2014-04-30 |
Ablynx N.V. |
Immunoglobulin single variable domains directed against ige
|
US20150158934A1
(en)
|
2011-09-09 |
2015-06-11 |
Ucl Business Plc |
Broadly neutralizing vhh against hiv-1
|
DK2747782T3
(en)
|
2011-09-23 |
2018-04-23 |
Ablynx Nv |
Long-term inhibition of interleukin-6-mediated signal transmission
|
US10112987B2
(en)
*
|
2012-01-09 |
2018-10-30 |
Icb International, Inc. |
Blood-brain barrier permeable peptide compositions comprising a vab domain of a camelid single domain heavy chain antibody against an amyloid-beta peptide
|
US10112988B2
(en)
|
2012-01-09 |
2018-10-30 |
Icb International, Inc. |
Methods of assessing amyloid-beta peptides in the central nervous system by blood-brain barrier permeable peptide compositions comprising a vab domain of a camelid single domain heavy chain antibody against an anti-amyloid-beta peptide
|
EP2820046B1
(en)
|
2012-02-27 |
2022-06-15 |
Ablynx N.V. |
Cx3cr1-binding polypeptides
|
USRE49625E1
(en)
|
2012-03-29 |
2023-08-29 |
Arizona Board Of Regents, A Body Corporate Of The State Of Arizona |
Nanoscale process to generate reagents selective for individual protein variants
|
AU2013240367A1
(en)
|
2012-03-29 |
2014-10-23 |
Arizona Board Of Regents, A Body Corporate Of The State Of Arizona, Acting For And On Behalf Of Arizona State University |
Nanoscale process to generate reagents selective for individual protein variants
|
TR201908638T4
(tr)
|
2012-03-30 |
2019-07-22 |
Boehringer Ingelheim Int |
Ang2 bağlayıcı moleküller.
|
US9328174B2
(en)
|
2012-05-09 |
2016-05-03 |
Novartis Ag |
Chemokine receptor binding polypeptides
|
CA2874309C
(en)
|
2012-05-24 |
2021-06-15 |
Vib Vzw |
Anti-macrophage mannose receptor single variable domains for targeting and in vivo imaging of tumor-associated macrophages
|
WO2014087010A1
(en)
|
2012-12-07 |
2014-06-12 |
Ablynx N.V. |
IMPROVED POLYPEPTIDES DIRECTED AGAINST IgE
|
CA2894225A1
(fr)
|
2012-12-17 |
2014-06-26 |
Laboratoire Francais Du Fractionnement Et Des Biotechnologies |
Utilisation d'anticorps monoclonaux pour le traitement de l'inflammation et d'infections bacteriennes
|
US9200068B2
(en)
|
2012-12-18 |
2015-12-01 |
Regents Of The University Of Minnesota |
Compositions and methods related to tauopathy
|
CA2899693C
(en)
|
2013-01-30 |
2023-03-14 |
Vib Vzw |
Novel chimeric polypeptides for screening and drug discovery purposes
|
EP3590578A1
(en)
|
2013-02-05 |
2020-01-08 |
VIB vzw |
Muscarinic acetylcholine receptor binding agents and uses thereof
|
US20150368357A1
(en)
|
2013-02-13 |
2015-12-24 |
Laboratoire Francais Du Fractionnement Et Des Biotechnologies |
Highly galactosylated anti-her2 antibodies and uses thereof
|
KR20150145225A
(ko)
|
2013-02-13 |
2015-12-29 |
라보라토이레 프란카이즈 듀 프락티온네먼트 에트 데스 바이오테크놀로지스 |
변경된 글리코실화를 갖는 세툭시맙 및 이의 용도
|
EP3594231A1
(en)
|
2013-02-13 |
2020-01-15 |
Laboratoire Français du Fractionnement et des Biotechnologies |
Highly galactosylated anti-tnf-alpha antibodies and uses thereof
|
CN105051067B
(zh)
|
2013-03-12 |
2020-04-17 |
分子模板公司 |
用于引起细胞内化的cd20结合免疫毒素及其使用方法
|
CN118028463A
(zh)
|
2013-03-14 |
2024-05-14 |
儿童医学中心公司 |
Cd36鉴定癌症对象以用于治疗的用途
|
AU2014229952B2
(en)
|
2013-03-15 |
2018-10-04 |
Vib Vzw |
Anti-macrophage mannose receptor single variable domains for use in cardiovascular diseases
|
NL1040254C2
(en)
|
2013-05-17 |
2014-11-24 |
Ablynx Nv |
Stable formulations of immunoglobulin single variable domains and uses thereof.
|
JP6415827B2
(ja)
*
|
2013-09-08 |
2018-10-31 |
株式会社テクノメデイカ |
紙装置を用いたトランスフェリンファミリータンパク質の検出
|
KR102665705B1
(ko)
|
2013-10-21 |
2024-05-14 |
다케다 파머수티컬 컴패니 리미티드 |
자가면역 질환의 진단 및 치료
|
EP2873679A1
(en)
*
|
2013-11-13 |
2015-05-20 |
F.Hoffmann-La Roche Ag |
Camelid single-domain antibody directed against amyloid bêta and methods for producing conjugates thereof
|
EP2873680A1
(en)
*
|
2013-11-13 |
2015-05-20 |
F.Hoffmann-La Roche Ag |
Oligopeptide and methods for producing conjugates thereof
|
EP2899208A1
(en)
|
2014-01-28 |
2015-07-29 |
F.Hoffmann-La Roche Ag |
Camelid single-domain antibody directed against phosphorylated tau proteins and methods for producing conjugates thereof
|
CA2946887A1
(en)
|
2014-04-24 |
2015-10-29 |
Immusant, Inc. |
Compositions comprising gluten peptides and uses thereof
|
RS63085B1
(sr)
|
2014-05-16 |
2022-04-29 |
Ablynx Nv |
Varijabilni domeni imunoglobulina
|
CA2949816A1
(en)
|
2014-05-16 |
2015-11-19 |
Children's Hospital Medical Center |
Methods for assessing responsiveness to asthma treatment based on vnn-1 expression and promoter methylation
|
NL2013007B1
(en)
|
2014-06-16 |
2016-07-05 |
Ablynx Nv |
Methods of treating TTP with immunoglobulin single variable domains and uses thereof.
|
NL2013661B1
(en)
|
2014-10-21 |
2016-10-05 |
Ablynx Nv |
KV1.3 Binding immunoglobulins.
|
EP3207048A4
(en)
|
2014-10-17 |
2018-05-30 |
The Broad Institute, Inc. |
Compositions and methods of treating muscular dystrophy
|
EP3230457B1
(en)
|
2014-12-09 |
2021-06-30 |
New York University |
Clostridial neurotoxin fusion proteins, propeptide fusions, their expression, and use
|
CN107406497A
(zh)
|
2014-12-19 |
2017-11-28 |
埃博灵克斯股份有限公司 |
半胱氨酸连接的纳米抗体二聚体
|
SG11201705986QA
(en)
|
2015-01-29 |
2017-08-30 |
Technophage Investigação E Desenvolvimento Em Biotecnologia Sa |
Antibody molecules and peptide delivery systems for use in alzheimer's disease and related disorders
|
AU2016239844B2
(en)
|
2015-04-02 |
2021-05-13 |
Ablynx N.V. |
Bispecific CXCR4-CD-4 polypeptides with potent anti-HIV activity
|
EP4345112A2
(en)
|
2015-05-13 |
2024-04-03 |
Ablynx N.V. |
T cell recruiting polypeptides based on cd3 reactivity
|
US10927186B2
(en)
|
2015-05-13 |
2021-02-23 |
Ablynx N.V. |
T cell recruiting polypeptides based on TCR alpha/beta reactivity
|
JOP20200312A1
(ar)
|
2015-06-26 |
2017-06-16 |
Novartis Ag |
الأجسام المضادة للعامل xi وطرق الاستخدام
|
WO2017004142A1
(en)
|
2015-06-29 |
2017-01-05 |
Children's Medical Center Corporation |
Treatment for myopathy
|
CA2998611A1
(en)
|
2015-09-14 |
2017-03-23 |
Leukemia Therapeutics, LLC |
Identification of novel diagnostics and therapeutics by modulating rhoh
|
NO2768984T3
(ja)
|
2015-11-12 |
2018-06-09 |
|
|
AU2016355568A1
(en)
|
2015-11-18 |
2018-06-21 |
Merck Sharp & Dohme Llc |
PD1/CTLA4 Binders
|
KR102095140B1
(ko)
|
2015-11-18 |
2020-03-31 |
머크 샤프 앤드 돔 코포레이션 |
Ctla4 결합제
|
CN108473585B
(zh)
|
2015-11-18 |
2022-04-05 |
默沙东公司 |
Pd1和/或lag3结合剂
|
BR112018010802A2
(pt)
|
2015-11-27 |
2018-11-27 |
Ablynx Nv |
polipeptídeos que inibem cd40l
|
AR106949A1
(es)
|
2015-12-04 |
2018-03-07 |
Boehringer Ingelheim Int |
Polipéptidos biparatópicos que antagonizan la señalización wnt en células tumorales
|
CA3022697A1
(en)
|
2016-05-02 |
2017-11-09 |
Ablynx Nv |
Treatment of rsv infection
|
TW201802121A
(zh)
|
2016-05-25 |
2018-01-16 |
諾華公司 |
抗因子XI/XIa抗體之逆轉結合劑及其用途
|
WO2018007442A1
(en)
|
2016-07-06 |
2018-01-11 |
Ablynx N.V. |
Treatment of il-6r related diseases
|
WO2018029182A1
(en)
|
2016-08-08 |
2018-02-15 |
Ablynx N.V. |
Il-6r single variable domain antibodies for treatment of il-6r related diseases
|
US11098113B2
(en)
|
2016-09-15 |
2021-08-24 |
Vib Vzw |
Immunoglobulin single variable domains directed against macrophage migration inhibitory factor
|
KR102665596B1
(ko)
|
2016-11-16 |
2024-05-14 |
아블린쓰 엔.브이. |
Cd123 및 tcr 알파/베타에 결합할 수 있는 t 세포 동원 폴리펩티드
|
WO2018099968A1
(en)
|
2016-11-29 |
2018-06-07 |
Ablynx N.V. |
Treatment of infection by respiratory syncytial virus (rsv)
|
US11168147B2
(en)
|
2016-12-23 |
2021-11-09 |
Novartis Ag |
Factor XI antibodies and methods of use
|
JP7186401B2
(ja)
|
2017-02-28 |
2022-12-09 |
フエー・イー・ベー・フエー・ゼツト・ウエー |
タンパク質の経口送達のための手段及び方法
|
TWI743346B
(zh)
*
|
2017-03-31 |
2021-10-21 |
國立大學法人東京大學 |
諾羅病毒抗體
|
US11891451B2
(en)
|
2017-05-11 |
2024-02-06 |
Vib Vzw |
Glycosylation of variable immunoglobulin domains
|
CN110637030A
(zh)
|
2017-05-31 |
2019-12-31 |
勃林格殷格翰国际有限公司 |
拮抗肿瘤细胞中Wnt信号传导的多肽
|
TWI826376B
(zh)
|
2017-06-02 |
2023-12-21 |
德商麥克專利有限公司 |
與adamts5、mmp13及聚集蛋白聚醣結合的多肽
|
KR20200013231A
(ko)
|
2017-06-02 |
2020-02-06 |
베링거 인겔하임 인터내셔날 게엠베하 |
항암 조합 요법
|
MX2019014400A
(es)
|
2017-06-02 |
2020-02-10 |
Merck Patent Gmbh |
Inmunoglobulinas que se unen a adamts.
|
BR112019025097A2
(pt)
|
2017-06-02 |
2020-07-28 |
Merck Patent Gmbh |
imunoglobulinas de ligação a mmp13
|
WO2018220225A1
(en)
|
2017-06-02 |
2018-12-06 |
Ablynx Nv |
Aggrecan binding immunoglobulins
|
WO2019016237A1
(en)
|
2017-07-19 |
2019-01-24 |
Vib Vzw |
AGENTS FOR CONNECTING TO SERUM ALBUMIN
|
EP3704160A1
(en)
|
2017-10-31 |
2020-09-09 |
VIB vzw |
Novel antigen-binding chimeric proteins and methods and uses thereof
|
CN112004826A
(zh)
|
2018-02-05 |
2020-11-27 |
自由大学基金会 |
反向激动性抗us28抗体
|
CA3089211A1
(en)
|
2018-02-06 |
2019-08-15 |
Ablynx Nv |
Methods of treating initial episode of ttp with immunoglobulin single variable domains
|
WO2019156566A1
(en)
|
2018-02-12 |
2019-08-15 |
Umc Utrecht Holding B.V. |
Bispecific molecules comprising gamma-delta tcr and t-cell or nk cell binding domain
|
WO2019155041A1
(en)
|
2018-02-12 |
2019-08-15 |
Vib Vzw |
Gβγ COMPLEX ANTIBODIES AND USES THEREOF
|
CA3092421A1
(en)
|
2018-03-01 |
2019-09-06 |
Vrije Universiteit Brussel |
Human pd-l1-binding immunoglobulins
|
WO2019226050A2
(en)
|
2018-05-24 |
2019-11-28 |
Wageningen Universiteit |
Novel viral anti-infective reagents
|
EP3636657A1
(en)
|
2018-10-08 |
2020-04-15 |
Ablynx N.V. |
Chromatography-free antibody purification method
|
WO2020080941A1
(en)
|
2018-10-16 |
2020-04-23 |
Umc Utrecht Holding B.V. |
Anti- low-density lipoprotein receptor-related protein 5/6 antibodies
|
WO2020130838A2
(en)
|
2018-12-21 |
2020-06-25 |
Qvq Holding B.V. |
Antibodies for preventing or treating candidiasis
|
GB201901608D0
(en)
|
2019-02-06 |
2019-03-27 |
Vib Vzw |
Vaccine adjuvant conjugates
|
EP4378485A2
(en)
|
2019-03-08 |
2024-06-05 |
LinXis B.V. |
Internalizing binding molecules targeting receptors involved in cell proliferation or cell differentiation
|
CN113646048A
(zh)
|
2019-03-29 |
2021-11-12 |
勃林格殷格翰国际有限公司 |
抗癌组合疗法
|
KR20210144736A
(ko)
|
2019-03-29 |
2021-11-30 |
베링거 인겔하임 인터내셔날 게엠베하 |
항암 조합 요법
|
JP2022529139A
(ja)
|
2019-04-02 |
2022-06-17 |
イミュネチューン・ベー・フェー |
免疫刺激組成物及びその使用
|
JP2022530549A
(ja)
|
2019-04-29 |
2022-06-29 |
コンフォ セラピューティクス エヌ.ブイ. |
膜貫通タンパク質、特にgpcrを伴う使用のためのスクリーニング方法及びアッセイ
|
WO2020221888A1
(en)
|
2019-04-30 |
2020-11-05 |
Vib Vzw |
Cystic fibrosis transmembrane conductance regulator stabilizing agents
|
WO2020239934A1
(en)
|
2019-05-28 |
2020-12-03 |
Vib Vzw |
Cd8+ t-cells lacking plexins and their application in cancer treatment
|
WO2020239945A1
(en)
|
2019-05-28 |
2020-12-03 |
Vib Vzw |
Cancer treatment by targeting plexins in the immune compartment
|
US20220324947A1
(en)
|
2019-08-05 |
2022-10-13 |
Stichting Vu |
Identification and Elimination of HCMV-Infected Cells
|
CN111748571B
(zh)
*
|
2019-10-11 |
2022-05-03 |
浙江禾霖生物科技有限公司 |
一种将枯草芽孢杆菌工程化为生产纳米抗体的多功能稳定平台的方法
|
EP4048703A1
(en)
|
2019-10-21 |
2022-08-31 |
Vib Vzw |
Nanodisc-specific antigen-binding chimeric proteins
|
MX2022005678A
(es)
|
2019-11-11 |
2022-10-18 |
Ibi Ag Innovative Bio Insecticides Ltd |
Nanocuerpos para el control de insectos y usos de los mismos.
|
US20220411495A1
(en)
|
2019-11-27 |
2022-12-29 |
Vib Vzw |
Positive allosteric modulators of the calcium-sensing receptor
|
GB201918279D0
(en)
|
2019-12-12 |
2020-01-29 |
Vib Vzw |
Glycosylated single chain immunoglobulin domains
|
EP4077372A1
(en)
|
2019-12-20 |
2022-10-26 |
Vib Vzw |
Nanobody exchange chromatography
|
WO2021140205A1
(en)
|
2020-01-10 |
2021-07-15 |
Confo Therapeutics N.V. |
Methods for generating antibodies and antibody fragments and libraries comprising same
|
WO2021156490A2
(en)
|
2020-02-06 |
2021-08-12 |
Vib Vzw |
Corona virus binders
|
JP2023514654A
(ja)
|
2020-02-25 |
2023-04-06 |
ブイアイビー ブイゼットダブリュ |
ロイシンリッチリピートキナーゼ2のアロステリック調節因子
|
US20230279115A1
(en)
|
2020-04-22 |
2023-09-07 |
Mabwell (shanghai) Bioscience Co., Ltd. |
Single variable domain antibody targeting human programmed death ligand 1 (pd-l1) and derivative thereof
|
WO2021229104A1
(en)
|
2020-05-15 |
2021-11-18 |
Université de Liège |
Anti-cd38 single-domain antibodies in disease monitoring and treatment
|
WO2022003156A1
(en)
|
2020-07-02 |
2022-01-06 |
Oncurious Nv |
Ccr8 non-blocking binders
|
IL300059A
(en)
|
2020-07-23 |
2023-03-01 |
Othair Prothena Ltd |
Anti-Abata antibodies
|
EP4214235A1
(en)
|
2020-09-16 |
2023-07-26 |
LinXis B.V. |
Internalizing binding molecules
|
CA3196737A1
(en)
|
2020-09-24 |
2022-03-31 |
Massimiliano Mazzone |
Combination of p2y6 inhibitors and immune checkpoint inhibitors
|
WO2022063957A1
(en)
|
2020-09-24 |
2022-03-31 |
Vib Vzw |
Biomarker for anti-tumor therapy
|
KR20230074527A
(ko)
|
2020-09-25 |
2023-05-30 |
아블린쓰 엔.브이. |
Il-13 및 ox40l을 표적으로 하는 면역글로불린 단일 가변 도메인을 포함하는 폴리펩티드
|
WO2022098745A1
(en)
|
2020-11-03 |
2022-05-12 |
Indi Molecular, Inc. |
Compositions, delivery systems, and methods useful in tumor therapy
|
WO2022098743A1
(en)
|
2020-11-03 |
2022-05-12 |
Indi Molecular, Inc. |
Compositions, imaging, and therapeutic methods targeting folate receptor 1 (folr1)
|
WO2022117569A1
(en)
|
2020-12-02 |
2022-06-09 |
Oncurious Nv |
A ccr8 antagonist antibody in combination with a lymphotoxin beta receptor agonist antibody in therapy against cancer
|
WO2022117572A2
(en)
|
2020-12-02 |
2022-06-09 |
Oncurious Nv |
An ltbr agonist in combination therapy against cancer
|
US11897951B2
(en)
|
2020-12-18 |
2024-02-13 |
Ablynx N.V. |
Polypeptides comprising immunoglobulin single variable domains targeting IL-6 and TNF-α
|
GB202020502D0
(en)
|
2020-12-23 |
2021-02-03 |
Vib Vzw |
Antibody composistion for treatment of corona virus infection
|
CA3206125A1
(en)
|
2020-12-24 |
2022-06-30 |
Vib Vzw |
Murine cross-reactive human ccr8 binders
|
US20240076391A1
(en)
|
2020-12-24 |
2024-03-07 |
Oncurious Nv |
Human ccr8 binders
|
US20240052044A1
(en)
|
2020-12-24 |
2024-02-15 |
Vib Vzw |
Non-blocking human ccr8 binders
|
CN113150140B
(zh)
*
|
2021-01-25 |
2022-11-04 |
山西农业大学 |
一种sox6二价纳米抗体及其应用
|
CN117794566A
(zh)
|
2021-02-05 |
2024-03-29 |
Vib研究所 |
沙贝病毒结合剂
|
CA3207548A1
(en)
|
2021-02-05 |
2022-08-11 |
Xavier Saelens |
Sarbecovirus binders
|
EP4294407A1
(en)
|
2021-02-17 |
2023-12-27 |
Vib Vzw |
Inhibition of slc4a4 in the treatment of cancer
|
WO2022175532A1
(en)
|
2021-02-19 |
2022-08-25 |
Vib Vzw |
Cation-independent mannose-6-phosphate receptor binders
|
WO2022199804A1
(en)
|
2021-03-24 |
2022-09-29 |
Vib Vzw |
Nek6 inhibition to treat als and ftd
|
WO2022216157A1
(en)
|
2021-04-09 |
2022-10-13 |
Stichting Radboud Universiteit |
Off the shelf proximity biotinylation enzyme
|
WO2022242892A1
(en)
|
2021-05-17 |
2022-11-24 |
Université de Liège |
Anti-cd38 single-domain antibodies in disease monitoring and treatment
|
WO2022258606A1
(en)
|
2021-06-07 |
2022-12-15 |
Gadeta B.V. |
Delta T-cell or Gamma T-cell receptor chains or parts thereof that mediate an anti-tumour or anti-infective response
|
TW202317625A
(zh)
|
2021-06-17 |
2023-05-01 |
德商百靈佳殷格翰國際股份有限公司 |
新穎三特異性結合分子
|
EP4359421A1
(en)
|
2021-06-23 |
2024-05-01 |
Vib Vzw |
Means and methods for selection of specific binders
|
CN117580865A
(zh)
|
2021-06-29 |
2024-02-20 |
山东先声生物制药有限公司 |
Cd16抗体及其应用
|
EP4378954A1
(en)
|
2021-07-30 |
2024-06-05 |
Shandong Simcere Biopharmaceutical Co., Ltd. |
Anti-pvrig/anti-tigit bispecific antibody and application
|
EP4377352A2
(en)
|
2021-07-30 |
2024-06-05 |
Vib Vzw |
Cation-independent mannose-6-phosphate receptor binders for targeted protein degradation
|
WO2023014222A1
(en)
|
2021-08-03 |
2023-02-09 |
Wageningen Universiteit |
Argonaute-based nucleic acid detection system
|
WO2023100944A1
(ja)
*
|
2021-12-01 |
2023-06-08 |
株式会社Epsilon Molecular Engineering |
ランダム領域搭載用フレームワーク配列を有するペプチド及びそのペプチドで構成されるペプチドライブラリ
|
WO2023111266A1
(en)
|
2021-12-17 |
2023-06-22 |
Ablynx Nv |
POLYPEPTIDES COMPRISING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS TARGETING TCRαβ, CD33 AND CD123
|
WO2023135198A1
(en)
|
2022-01-12 |
2023-07-20 |
Vib Vzw |
Human ntcp binders for therapeutic use and liver-specific targeted delivery
|
WO2023148397A1
(en)
|
2022-02-07 |
2023-08-10 |
Vib Vzw |
Engineered stabilizing aglycosylated fc-regions
|
WO2023198848A1
(en)
|
2022-04-13 |
2023-10-19 |
Vib Vzw |
An ltbr agonist in combination therapy against cancer
|
WO2023222825A1
(en)
|
2022-05-18 |
2023-11-23 |
Vib Vzw |
Sarbecovirus spike s2 subunit binders
|
WO2023227594A1
(en)
|
2022-05-24 |
2023-11-30 |
Gadeta Bv |
Novel deltat-cell receptor chains, gammat-cell receptor chains, or parts thereof
|
WO2023237541A1
(en)
|
2022-06-07 |
2023-12-14 |
Gadeta B.V. |
Delta t-cell or gamma t-cell receptor chains or parts thereof that mediate an anti-tumour or anti-infective response
|
WO2024008755A1
(en)
|
2022-07-04 |
2024-01-11 |
Vib Vzw |
Blood-cerebrospinal fluid barrier crossing antibodies
|
US20240052065A1
(en)
|
2022-07-15 |
2024-02-15 |
Boehringer Ingelheim International Gmbh |
Binding molecules for the treatment of cancer
|
WO2024013401A1
(en)
|
2022-07-15 |
2024-01-18 |
Gadeta B.V. |
Novel method for identifying gamma t-cell (or delta t-cell) receptor chains (or gammadelta t-cell receptors) or fragments thereof that mediate an anti-tumour or an anti-infective response
|
US20240132624A1
(en)
|
2022-07-27 |
2024-04-25 |
Ablynx N.V. |
Polypeptides binding to a specific epitope of the neonatal fc receptor
|
WO2024068744A1
(en)
|
2022-09-27 |
2024-04-04 |
Vib Vzw |
Antivirals against human parainfluenza virus
|
WO2024084203A1
(en)
*
|
2022-10-18 |
2024-04-25 |
Isogenica Limited |
Single domain antibodies binding to albumin
|
WO2024083843A1
(en)
|
2022-10-18 |
2024-04-25 |
Confo Therapeutics N.V. |
Amino acid sequences directed against the melanocortin 4 receptor and polypeptides comprising the same for the treatment of mc4r-related diseases and disorders
|
WO2024096735A1
(en)
|
2022-10-31 |
2024-05-10 |
Stichting Amsterdam UMC |
Single domain anti-cd169 antibodies
|
WO2024101989A1
(en)
|
2022-11-08 |
2024-05-16 |
Stichting Amsterdam UMC |
Activation inducible antigen receptors for adoptive immunotherapy
|
WO2024105091A1
(en)
|
2022-11-15 |
2024-05-23 |
Imec Vzw |
Method and system for droplet manipulation
|